Discovery Structure Properties Gene, mRNA, and precursor Receptors Agonists Clinical implications
ChemicalBook > CAS DataBase List > Uroguanylin (human)

Uroguanylin (human)

Discovery Structure Properties Gene, mRNA, and precursor Receptors Agonists Clinical implications
Product Name
Uroguanylin (human)
CAS No.
154525-25-4
Chemical Name
Uroguanylin (human)
Synonyms
UROGUANYLIN;UGN (HUMAN);UROGUANYLIN (HUMAN);Uroguanylin >=90% (HPLC);Uroguanylin (huMan) UGN (huMan);Uroguanylin Topoisomer A (human);ASN-ASP-ASP-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU;H-ASN-ASP-ASP-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU-OH;asn-asp-asp-cys-glu-leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu [disulfide bridges: 4-12, 7-15];ASN-ASP-ASP-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR- GLY-CYS-LEU(DISULFIDE BRIDGE: CYS4-CYS12, CYS7-CYS15)
CBNumber
CB6118651
Molecular Formula
C64H102N18O26S4
Formula Weight
1667.86
MOL File
154525-25-4.mol
More
Less

Uroguanylin (human) Property

Boiling point:
2112.5±65.0 °C(Predicted)
Density 
1.48±0.1 g/cm3(Predicted)
storage temp. 
−20°C
pka
3.61±0.21(Predicted)
More
Less

Safety

WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
U5131
Product name
Uroguanylin
Purity
≥90% (HPLC)
Packaging
0.1mg
Price
$914
Updated
2024/03/01
Usbiological
Product number
U2585
Product name
Uroguanylin
Packaging
1mg
Price
$531
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
PEP0004564
Product name
UROGUANYLIN
Purity
95.00%
Packaging
0.1MG
Price
$1073
Updated
2021/12/16
More
Less

Uroguanylin (human) Chemical Properties,Usage,Production

Discovery

UGN was first isolated from opossum urine in 1993 and was identified in humans in 1994. In nonmammals, ugn was first cloned from the eel in 2001. Also, in other vertebrates, ugn has been found. An ugn-like sequence is observed in the nucleotide database of an invertebrate, Ciona intestinalis. lgn was first cloned from the opossum in 1999.

Structure

UGN consists of 15–17 aa residues that are released from the C-terminus of proUGN. The fourth and 12th Cys and the seventh and 15th Cys form a disulfide bond, respectively, and the two rings give rise to the formation of two stereoisomers, of which only one is active. Some UGNs have a C-terminal extension , which may contribute to stabilizing the active isomer. The ninth aa residue is nonaromatic and thus resistant to chymotrypsin-like proteases in the renal tubule. These features are shared among all UGNs found. Lgn possesses a nonaromatic aa residue at the same position, but lacks the 15th Cys residue, resulting in the lack of the second disulfide ring. Most of the 15–17 aa residues are conserved across vertebrate species, though some are different, especially in Lgn. In some species, 1–2 extra aa residues are present at the C-terminus. The prosegment is variable except for the conserved Leu/Lys-rich region located in the upstream of proUGN.

Properties

Mr and pI of human UGN are 1667.9 and 3.19, respectively. UGN is soluble in water, alcohol, and watercontaining organic solvent. UGN in solution is stable at neutral pH. UGN in water is stable at -20°C for more than 1 year. Solubilization and storage methods of Lgn may be similar to those of UGN.

Gene, mRNA, and precursor

In humans, UGN consisting of three exons is located on chromosome 1 (1p34.2) with GN. Similar colocalization on a chromosome is observed in other vertebrate species. The translated preproUGN of 112 aa residues contains the signal peptide and the mature peptide. ProUGN is released from cells and processed into UGN during circulation or on the intestinal and renal tubular lumen. The mature region is well or moderately conserved among vertebrate UGNs or in opossum Lgn, respectively , although the precise processing mechanism needs to be investigated in nonmammalian Ugns. A splice variant is suggested in the European eel.

Receptors

GUCY2C, a membrane protein consisting of an extracellular ligand-binding domain, a membrane-spanning domain, a kinase-like domain, and a cyclase catalytic domain, is the primary receptor for both UGN and GN .A shorter GUCY2C, a splice variant, is expressed in some colorectal cancer cells. In contrast to one GUCY2C in mammals, at least two gucy2c exist in teleost fish. In eels, at the cGMP production, Gucy2c1 is stimulated primarily by Ugn while Gucy2c2 responds to Ugn less effectively than Gn  Structure of human preproUGN (A) and UGN (B), and comparison of vertebrate UGN and opossum Lgn (C). (B) The schematic view is based on previous reports. (C) Arrowheads indicate the ninth aa residue characteristic to UGN. 350 32B.  At least one gucy2c sequence has been found in other vertebrates. Furthermore, another type of GC receptor, GUCY2D, expressing in the murine olfactory epithelia, is reported to be stimulated by GN and UGN. The presence of additional UGN receptor(s) has been predicted. In the opossum, Gucy2c is also a receptor for Lgn.

Agonists

Sts produced by enterotoxigenic E. coli are exogenous ligands of GUCY2C. Sts exert stronger effects for GUCY2C than UGN in mammals and substantial effects for one medaka Gucy2c (Olgc9), but not for other fish cloned Gucy2cs. Other major agonists are synthetic peptides modified from GN/UGN, linaclotide and plecanatide.

Clinical implications

There is no known disease related to UGN. A function for the intestinal fluid secretion has led scientists to apply UGN for anticonstipation. The facts of decreased UGN mRNA expression in some colorectal cancers and promoted epithelial proliferation in the loss of UGN suggest a clinical application of UGN to prevent the enlargement of colorectal tumors. The evidence of decreased UGN in obesity and the implication of UGN as an enterocerebral natriuretic factor could also be keys for UGN-utilizing improvement of obesity.

General Description

Uroguanylin is a peptide hormone consisting of 15–17 aa residues that binds to the guanylyl cyclase C (GUCY2C) receptor to produce cGMP, which is often more effective than guanylin (GN). It plays important roles in regulating ion and water transport and maintaining epithelial homeostasis in the intestine and kidney. Opossum lymphoguanylin (Lgn) is more similar to UGN than to GN, and thus, is described here.

Clinical Use

Two UGN/GN agonists, linaclotide and plecanatide, have recently been approved in the United States, European Union, Japan, and other countries for treatment of irritable bowel syndrome and chronic constipation. They have also been approved in the United States for treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation, respectively.

Uroguanylin (human) Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Uroguanylin (human) Suppliers

GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Fax
86-21-61263399
Email
ymbetter@glbiochem.com
Country
China
ProdList
9981
Advantage
64
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Country
China
ProdList
42958
Advantage
64
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
15402
Advantage
60
Cellmano Biotech Limited
Tel
0551-65326643 18156095617
Fax
0551-65326641
Email
info@cellmano.com
Country
China
ProdList
1011
Advantage
55
Nanjing Leon Biological Technology Co., Ltd.
Tel
17705183659
Fax
84523390
Email
sales@njleonbiotech.com
Country
China
ProdList
5501
Advantage
55
Nanjing Peptide Biotech Ltd.
Tel
025-025-58361106-805-805 13082558573
Fax
025-58361106-806
Email
liugang@njpeptide.com
Country
China
ProdList
9980
Advantage
55
Hangzhou Peptidego Biotech Co.,Ltd.
Tel
0571-87213919
Fax
0571-87213919
Email
Eric@peptidego.com
Country
China
ProdList
6756
Advantage
58
Nanjing Meihao Pharmaceutical Technology Co., Ltd.
Tel
meitaochem@126.com
Email
meitaochem@126.com
Country
China
ProdList
19103
Advantage
58
Hangzhou Go Top Peptide Biotech
Tel
0571-88211921
Email
sales1@gotopbio.com
Country
CHINA
ProdList
2609
Advantage
58
Career Henan Chemica Co
Tel
+86-0371-86658258 +8613203830695
Fax
0371-86658258
Email
laboratory@coreychem.com
Country
China
ProdList
30240
Advantage
58
Chengdu Peter-like Biotechnology Co., Ltd.
Tel
028-81700200 18108052721
Email
2850505130@qq.com
Country
China
ProdList
5176
Advantage
58
Cellmano Biotech Limited
Tel
0551-65326643 18156095617
Fax
0551-65326641
Email
info@cellmano.com
Country
China
ProdList
999
Advantage
58
Nanjing chengqimei Biotechnology Co., Ltd
Tel
19850819832
Email
2173594524@qq.com
Country
China
ProdList
2638
Advantage
58
Gill polypeptide biopharmaceutical (dalian) co., LTD
Tel
021-61263455 13167021076
Email
amy@glschina.com
Country
China
ProdList
8745
Advantage
58
Nanjing TGpeptide Biotechnology Co.,Ltd.
Tel
18115476705
Email
sales@tgpeptide.com
Country
China
ProdList
3058
Advantage
58
Hangzhou Go Top Peptide Biotech
Tel
0571-88211921 13355716090
Email
Sales@gotopbio.com
Country
China
ProdList
2859
Advantage
58
Energy Chemical
Tel
021-58432009 400-005-6266
Fax
021-58436166
Email
marketing1@energy-chemical.com
Country
China
ProdList
44808
Advantage
58
TCI (Shanghai) Chemical Trading Co., Ltd.
Tel
021-021-61109150
Fax
021-61105897
Email
sales@tcisct.com
Country
China
ProdList
31121
Advantage
58
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
13675144456
Email
alan.chow@synzest.com
Country
China
ProdList
9470
Advantage
58
Chengdu Jinglin Biotechnology Co., Ltd.
Tel
17711399154
Email
3211919385@qq.com
Country
China
ProdList
1815
Advantage
58
Shaoxing Junyu Biotechnology Co., LTD
Tel
0571-88211921 15572296305
Email
sales4@gotopbio.com
Country
China
ProdList
5128
Advantage
58
Hangzhou Sinoda Pharmaceutical Technology Co. LTD
Tel
0571-87213919 17306812703
Email
3007955328@qq.com
Country
China
ProdList
6445
Advantage
58
Hangzhou Baige Pharmaceutical Technology Co. , Ltd.
Tel
0571-85350119 15888826472
Email
15888826472@163.com
Country
China
ProdList
2729
Advantage
58
Shanghai HongTide Biotechnology Co.,Ltd.
Tel
19961912513
Email
sales@hongtide.com
Country
China
ProdList
4597
Advantage
58
Combio (Suzhou) Ltd.
Tel
0512-51886999 17706251929
Email
office@combiosz.com
Country
China
ProdList
2981
Advantage
58
https://hanhongsci.com/
Tel
021-54306202 18917919676
Email
info@hanhongsci.com
Country
China
ProdList
29977
Advantage
58
Shanghai Toyang Biotechnology Co., LTD
Tel
021-59555769 13524932310
Fax
021-50342869
Email
1405894150@qq.com
Country
China
ProdList
8221
Advantage
58
Nanjing Yushengkang Biotechnology Co., Ltd
Tel
13327808530
Email
2670965693@qq.com
Country
China
ProdList
2179
Advantage
58
Zhejiang Jiekun Biotechnology Co., Ltd
Tel
0571-88211951 13735575465
Email
sales1@gotopbio.com
Country
China
ProdList
4904
Advantage
58
Taiyuan Bailihengkang Biotechnology Co., Ltd
Tel
19135651983 19135651983
Email
18611134419@163.com
Country
China
ProdList
4416
Advantage
58
Hangzhou Beiputai Biopharmaceutical Co., Ltd
Tel
0571-85350119 13305819357
Email
bptsales@163.com
Country
China
ProdList
3850
Advantage
58
Changsha MOL Changes Biotechnology Co., Ltd.
Tel
+8619375158599
Email
info@molchanges.com
Country
China
ProdList
5225
Advantage
58
Shenzhen Nexconn Pharmatechs Ltd
Tel
+86-755-89396905 +86-15013857715
Email
admin@nexconn.com
Country
China
ProdList
10310
Advantage
58
Zhejiang Hangyu API Co., Ltd
Tel
+8617531972939
Email
anna@api-made.com
Country
China
ProdList
2943
Advantage
58
Nanjing TGpeptide
Tel
+86-13347807150 +86-13347807150
Email
support@tgpeptide.com
Country
China
ProdList
3279
Advantage
58
Chengdu Youngshe Chemical Co., Ltd.
Tel
+8618108235634
Email
Cecilia@youngshechem.com
Country
China
ProdList
2345
Advantage
58
Shanghai Seebio Biotech. Inc
Tel
--
Fax
--
Email
service@seebio.cn
Country
China
ProdList
2849
Advantage
65
Guangzhou WeiBo Chemical Co., Ltd.
Tel
--
Fax
--
Email
weibochem@163.com
Country
China
ProdList
6187
Advantage
67
Advanced Technology & Industrial Co., Ltd.
Tel
--
Fax
--
Email
sales@advtechind.com
Country
China
ProdList
6523
Advantage
75

154525-25-4, Uroguanylin (human)Related Search:


  • UGN (HUMAN)
  • UROGUANYLIN
  • UROGUANYLIN (HUMAN)
  • asn-asp-asp-cys-glu-leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu [disulfide bridges: 4-12, 7-15]
  • H-ASN-ASP-ASP-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU-OH
  • H-ASN-ASP-ASP-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU-OH, (DISULFIDE BONDS BETWEEN CYS4 AND CYS12/CYS7 AND CYS15)
  • ASN-ASP-ASP-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU
  • ASN-ASP-ASP-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR- GLY-CYS-LEU(DISULFIDE BRIDGE: CYS4-CYS12, CYS7-CYS15)
  • Uroguanylin (huMan) UGN (huMan)
  • Uroguanylin Topoisomer A (human)
  • L-Leucine, L-asparaginyl-L-α-aspartyl-L-α-aspartyl-L-cysteinyl-L-α-glutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (4→12),(7→15)-bis(disulfide)
  • Uroguanylin >=90% (HPLC)
  • 154525-25-4
  • C64H102N18O26S4
  • Amino Acids and Peptides
  • Biochemicals and Reagents
  • BioChemical
  • Guanylate Cyclase Activators
  • Miscellaneous Peptides
  • Peptides
  • Peptide